Intravenous versus subcutaneous epo: is the cost benefit acceptable?

Autor:	Marco D'Amico, Ferruccio Conte, Mario Fraticelli
Rok vydání:	2003
Předmět:	medicine.medical_specialty Text mining Nephrology business.industry medicine Cost benefit Intensive care medicine business
Zdroj:	American Journal of Kidney Diseases. 41:1122
ISSN:	0272-6386
DOI:	10.1016/s0272-6386(03)00288-9
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::afe3402e9ed416379a9463c940839d31 https://doi.org/10.1016/s0272-6386(03)00288-9 Zobrazit plný text záznamu